Representative Matters

In his practice, Mr. Dougall has:

• Represented an investment advisor, its managed venture capital funds and its board representative in fiduciary duty litigation concerning a publicly traded tech company.
• Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in various health care fraud and antitrust investigations by the United States Department of Justice and by State Attorneys General.
• Represented a very senior and global supervising managing director of an international investment bank in an accounting fraud investigation by the United States Department of Justice and the Securities and Exchange Commission.
• Represented a hedge fund in a corruption investigation by a State Attorney General.
• Represented the national brand manager of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
• Represented the division president of a North American corporation in a bid rigging investigation by the Antitrust Division of the United States Department of Justice.
• Represented a very senior and supervising managing director of an international investment bank in a securities fraud investigation by a State Attorney General.
• Represented an international investment bank in connection with conducting diligence concerning a health care industry issuer.
• Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in a health care fraud investigation by the United States Department of Justice.
• Represented a U.S. regional sales director of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
• Represented an international security consultant in an investigation under the Foreign Corrupt Practice Act by the United States Department of Justice.
• Represented individuals in an investigation of a multinational and publicly traded pharmaceutical maker's manufacturing practices by the United States Department of Justice.
• Represented a corporation that provided management services to health care providers in False Claims Act litigation brought by the United States Department of Justice and the New York State Attorney General.
• Represented a corporate director and officer of a publicly traded petroleum company in a stock manipulation investigation by the United States Department of Justice and the Securities and Exchange Commission.

top of page